Ferroptosis induction via targeting metabolic alterations in head and neck cancer

被引:8
|
作者
Lee, Jaewang [1 ,2 ]
Roh, Jong-Lyel [1 ,2 ]
机构
[1] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam 13496, Gyeonggi Do, South Korea
[2] CHA Univ, Gen Grad Sch, Dept Biomed Sci, Seongnam, South Korea
基金
新加坡国家研究基金会;
关键词
Metabolism; Mitochondria; Ferroptosis; Lipid peroxidation; Head and neck cancer; SQUAMOUS-CELL CARCINOMA; CISPLATIN-RESISTANT HEAD; NASOPHARYNGEAL CARCINOMA; LIPID DROPLETS; TUMOR-GROWTH; INHIBITION; IRON; DEATH; CELECOXIB; METASTASIS;
D O I
10.1016/j.critrevonc.2022.103887
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ferroptosis is a newly regulated cell death induced by the accumulation of iron-mediated lipid peroxidation. The alteration of cancer metabolism may contribute to proliferation, metastasis, and treatment resistance in human cancers, implicating the sensitivity to ferroptosis induction. Altered metabolism in cancer cells regulates oxidative stresses and changes metabolism intermediates, contributing to their deregulated growth and prolif-eration. Cancer metabolic changes toward the elevation of cellular free iron and polyunsaturated fatty acids sensitize cancer cells to lipid peroxidation toxicity tightly linked to ferroptosis. The altered metabolism in cancers can be served as a promising target to reverse cancer therapeutic resistance by ferroptosis induction to selectively kill cancer cells while sparing normal cells. The role of mitochondria and lipid metabolism in inducing ferroptosis in head and neck cancer (HNC) has been elucidated in previous studies. Ferroptosis is receiving attention in cancer research as treating cancers altering cellular metabolism and refractory from conventional therapies. More in-depth studies are needed to develop highly therapeutic drugs and practical methods to induce ferroptosis in diverse cancer cells and tumor microenvironments effectively. Therefore, this review intends to understand the altered metabolism and find new therapeutic possibilities using ferroptosis in HNC.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Promotion of ferroptosis in head and neck cancer with divalent metal transporter 1 inhibition or salinomycin
    Lee, Jaewang
    Roh, Jong-Lyel
    HUMAN CELL, 2023, 36 (03) : 1090 - 1098
  • [32] Induction Chemotherapy in the Management of Head and Neck Cancer
    Fury, Matthew G.
    Shah, Jatin P.
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (04) : 292 - 298
  • [33] Targeting ferroptosis in cardio-metabolic-diseases: Mechanisms and therapeutic prospects
    Zhang, Jia-Bao
    Tong, Jie
    Sun, Di-Yang
    Fu, Jiang-Tao
    Li, Dong-Jie
    Wang, Pei
    MEDICINAL RESEARCH REVIEWS, 2023, 43 (03) : 683 - 712
  • [34] Metabolic Regulation of Ferroptosis in Cancer
    Kim, Min Ji
    Yun, Greg Jiho
    Kim, Sung Eun
    BIOLOGY-BASEL, 2021, 10 (02): : 1 - 21
  • [35] Molecular techniques and genetic alterations in head and neck cancer
    Ha, Patrick K.
    Chang, Steven S.
    Glazer, Chad A.
    Califano, Joseph A.
    Sidransky, David
    ORAL ONCOLOGY, 2009, 45 (4-5) : 335 - 339
  • [36] Targeting ferroptosis, the achilles' heel of breast cancer: A review
    Liu, Yang
    Hu, Yueting
    Jiang, Yi
    Bu, Jiawen
    Gu, Xi
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] Immune alterations and immunotherapy prospects in head and neck cancer
    Varilla, Vincent
    Atienza, Jonessa
    Dasanu, Constantin A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (09) : 1241 - 1256
  • [38] Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy
    Maru, Devangkumar
    Hothi, Akhil
    Bagariya, Chintan
    Kumar, Anmol
    CURRENT CANCER DRUG TARGETS, 2022, 22 (03) : 234 - 244
  • [39] MitoTam induces ferroptosis and increases radiosensitivity in head and neck cancer cells
    Reinema, F. V.
    Hudson, N.
    Adema, G. J.
    Peeters, W. J. M.
    Neuzil, J.
    Stursa, J.
    Werner, L.
    Sweep, F. C. G. J.
    Bussink, J.
    Span, P. N.
    RADIOTHERAPY AND ONCOLOGY, 2024, 200
  • [40] A Ferroptosis-Related Gene Signature for Predicting the Prognosis and Drug Sensitivity of Head and Neck Squamous Cell Carcinoma
    Lu, Wei
    Wu, Yihua
    Huang, Shengyun
    Zhang, Dongsheng
    FRONTIERS IN GENETICS, 2021, 12